- Researchers confirm that vaccines are likely to protect against variants
- Two variants of SARS-CoV-2 have been reported from UK and South Africa
- South Africa variant allows the virus to evade immune responses: Research
New York: The tests conducted on two different variants of the coronavirus show that one of the two monoclonal antibodies in Regeneron’s cocktail therapy can neutralize both, despite the mutations, researchers reported on Wednesday (January 27). According to CNN, the tests also confirm that vaccines are likely to protect people against both the variant first seen in Britain and known as B.1.1.7 and another first noted in South Africa, called B.1.135. However, the mutations in B.1.135 do allow the virus to evade immune responses a little more, the team, led by Dr David Ho at Columbia University’s Aaron Diamond AIDS Research Center, reported in a pre-print report — one not yet published in a peer-reviewed journal.
Also Read: Covaxin Effectively Neutralises UK Variant Of COVID-19: Indian Council of Medical Research
The cocktail has been granted emergency use authorization (EUA) by the US Food and Drug Administration (FDA). It was used to treat former US President Donald Trump when he was tested positive for COVID-19 last year.
As we expected, the virus continues to mutate, and these data show the continued ability of REGEN-COV to neutralize emerging strains, further validating our multi-antibody cocktail approach to infectious diseases, Regeneron president Dr George Yancopoulos said in a statement, as quoted by CNN.
Dr Yancopoulos added, “With two complementary antibodies in one therapeutic, even if one has reduced potency, the risk of the cocktail losing efficacy is significantly diminished, since the virus would need to mutate in multiple distinct locations to evade both antibodies.”
Also Read: Vaccinated People May Still Transmit COVID-19, Warns England’s Chief Medic
The team led by Dr Ho tested convalescent plasma from 20 patients who recovered from COVID-19, and also blood from 22 people who got two doses of either Pfizer’s or Moderna’s coronavirus vaccines. CNN further reported that the team also tested Eli Lilly and Company’s single monoclonal antibody treatment, which also has a EUA. The mutations in B.1.1.7 had small effects if any. But one mutation especially, in B.1.135, did reduce the efficacy of the immune response in convalescent plasma, in both vaccines, of one of Regeneron’s antibodies and of Lilly’s antibody, they said. The same mutation is found in a variant first seen in Brazil.
Mutationally, this virus is traveling in a direction that could ultimately lead to escape from our current therapeutic and prophylactic interventions directed to the viral spike, Dr Ho’s team wrote as reported by CNN.
“If the rampant spread of the virus continues and more critical mutations accumulate, then we may be condemned to chasing after the evolving SARS-CoV-2 continually, as we have long done for influenza virus,” it added.
The team also said that the world must vaccinate people faster and, in the meantime, double down on measures to stop the spread of the virus, such as the use of masks.
Also Read: Experts Appeal Taking COVID-19 Vaccine Shot To Break The Chain Of Transmission And Avoid Another Peak
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (Water, Sanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollution, waste management, plastic ban, manual scavenging and sanitation workers and menstrual hygiene.